This year, we’re hosting an evening during Slush week on a question we think deserves more than a hallway chat: is longevity actually a business, or just a well-funded wellness trend?
Join us for an informal panel discussion and drinks with some of the sharpest minds at the intersection of medicine, health tech, and venture capital. No slide decks, no pitch theatre, just a direct conversation and good company.
Moderator: Isak Rautio, Founder and Host at Futucast
Panellists: Antti Kangas, Founder & CTO, Nightingale Health, Jani Tikkanen, MD, Adjunct Professor & Anders Carlberg, Senior Partner, Dittmar & Indrenius
On the table:
- Is ageing good business?
- GLP-1 drugs: a preview of a public health revolution, or just the first act?
- Biohacking culture: growth engine or credibility problem?
- Where does the value actually sit?
- Could Finland become a longevity hub, or is it already one?
Date: Tuesday 17 November 2026 at 17.30
Program: 17.30 Welcome drinks, 18.00 Panel discussion, 18.30 Networking
Inquiries and event registration: thinkingahead@dittmar.fi
This is for: investors, founders, and healthcare and life science professionals.
